Results 91 to 100 of about 88,385 (210)

Oral candidiasis as a clinical marker of highly active antiretroviral treatment failure in HIV-infected patients

Infectio
Introduction: Oral candidiasis is an opportunistic infection that is readily detectable in the clinic. It has been used to assess the immune status of HIV patients as well as the effectiveness of highly active antiretroviral therapy.
Sandra Lopez-Verdin, Amalia Torrecilla-Ramirez, Ana Cristina Horta-Sandoval, Jaime Federico Andrade-Villanueva, Ronell Bologna-Molina   +4 more
doaj   +1 more source

Anemia and Related Factors Among Highly Active Antiretroviral Therapy Experienced Children in Hawassa Comprehensive Specialized Hospital, Southern Ethiopia: Emphasis on Patient Management

Drug, Healthcare and Patient Safety, 2020
Demissie Assegu Fenta,1 Metsihet Mohammed Nuru,1 Tilahun Yemane,2 Yaregal Asres,3 Temesgen Bizuayehu Wube1 1School of Medical Laboratory, College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia; 2School of Medical Laboratory ...
Fenta DA, Nuru MM, Yemane T, Asres Y, Wube TB   +4 more
doaj  

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Proceedings of the National Academy of Sciences of the United States of America, 1997
T. Chun, L. Stuyver, Stephanie B. Mizell, L. Ehler, J. Mican, M. Baseler, A. Lloyd, M. Nowak, A. Fauci   +8 more
semanticscholar   +1 more source

Gynaecomastia associated with highly active antiretroviral therapy (HAART)

Journal of Radiology Case Reports, 2010
There is a global Acquired Immune Deficiency Syndrome (AIDS) epidemic. It is estimated that the total number of people living with Human Immune deficiency Virus (HIV) is 33.2 million in the year 2007. An estimated 2.1 million people died from AIDS in 2007.
openaire   +2 more sources

Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort.

Lancet Public Health, 2017
S. Croxford, A. Kitching, S. Desai, M. Kall, M. Edelstein, A. Skingsley, F. Burns, A. Copas, A. Brown, A. Sullivan, V. Delpech   +10 more
semanticscholar   +1 more source

Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

Journal of Acquired Immune Deficiency Syndromes, 2006
F. Palella, R. Baker, A. Moorman, J. Chmiel, K. Wood, J. Brooks, S. Holmberg   +6 more
semanticscholar   +1 more source

Naringenin attenuates highly active antiretroviral therapy‐induced sperm DNA fragmentations and testicular toxicity in Sprague‐Dawley rats

Andrology, 2018
M. Adana, M. Adana, E. N. Akang, E. N. Akang, Aniekan I. Peter, Aniekan I. Peter, A. I. Jegede, E. Naidu, C. Tiloke, Anil A. Chuturgoon, O. Azu   +10 more
semanticscholar   +1 more source

HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy

Cancer Epidemiology, Biomarkers and Prevention, 2016
Xuesong Han, A. Jemal, E. Hulland, Edgar P. Simard, L. Nastoupil, Elizabeth E. Ward, C. Flowers   +6 more
semanticscholar   +1 more source

HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review

HIV Medicine, 2016
CT Lambert, P. Sandesara, B. Hirsh, LJ Shaw, W. Lewis, A. Quyyumi, R. Schinazi, W. Post, L. Sperling   +8 more
semanticscholar   +1 more source

Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages

AIDS Research and Human Retroviruses, 2015
S. Cribbs, J. Lennox, A. Caliendo, L. Brown, D. Guidot   +4 more
semanticscholar   +1 more source